APA
de Nonneville A., Gonçalves A., Zemmour C., Classe J. M., Cohen M., Lambaudie E., Reyal F., Scherer C., Muracciole X., Colombo P. E., Giard S., Rouzier R., Villet R., Chopin N., Darai E., Garbay J. R., Gimbergues P., Sabiani L., Coutant C., Sabatier R., Bertucci F., Boher J. M. & Houvenaeghel G. (20171207). Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study. : Breast cancer research and treatment.
Chicago
de Nonneville Alexandre, Gonçalves Anthony, Zemmour Christophe, Classe Jean M, Cohen Monique, Lambaudie Eric, Reyal Fabien, Scherer Christophe, Muracciole Xavier, Colombo Pierre E, Giard Sylvia, Rouzier Roman, Villet Richard, Chopin Nicolas, Darai Emile, Garbay Jean R, Gimbergues Pierre, Sabiani Laura, Coutant Charles, Sabatier Renaud, Bertucci François, Boher Jean M and Houvenaeghel Gilles. 20171207. Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study. : Breast cancer research and treatment.
Harvard
de Nonneville A., Gonçalves A., Zemmour C., Classe J. M., Cohen M., Lambaudie E., Reyal F., Scherer C., Muracciole X., Colombo P. E., Giard S., Rouzier R., Villet R., Chopin N., Darai E., Garbay J. R., Gimbergues P., Sabiani L., Coutant C., Sabatier R., Bertucci F., Boher J. M. and Houvenaeghel G. (20171207). Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study. : Breast cancer research and treatment.
MLA
de Nonneville Alexandre, Gonçalves Anthony, Zemmour Christophe, Classe Jean M, Cohen Monique, Lambaudie Eric, Reyal Fabien, Scherer Christophe, Muracciole Xavier, Colombo Pierre E, Giard Sylvia, Rouzier Roman, Villet Richard, Chopin Nicolas, Darai Emile, Garbay Jean R, Gimbergues Pierre, Sabiani Laura, Coutant Charles, Sabatier Renaud, Bertucci François, Boher Jean M and Houvenaeghel Gilles. Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study. : Breast cancer research and treatment. 20171207.